A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin Mutation



Status:Recruiting
Conditions:Healthy Studies, Neurology, Neurology, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 65
Updated:9/26/2018
Start Date:September 14, 2018
End Date:September 30, 2020
Contact:Study Lead
Email:info@alector.com
Phone:4152315660

Use our guide to learn which trials are right for you!

A First in Human Phase 1 Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin Mutation

A first in human phase 1 study in healthy volunteers and Granulin mutation causative of
frontotemporal dementia to assess AL001 safety, tolerability, pharmacokinetics, and
pharmacodynamics

This is a first-in-human Phase 1 study designed to investigate the safety, tolerability, PK
and PD of intravenously administered AL001 in Healthy Volunteers and asymptomatic FTD-GRN
mutation carriers.

Inclusion Criteria:

- BMI 18.0-35.0 kg/m2

- 45-120 kg, inclusive

- At screening, females must be non-pregnant and non-lactating, or of nonchildbearing
potential (either surgically sterilized or physiologically incapable of becoming
pregnant, or at least 1-year postmenopausal (amenorrhoea duration of 12 consecutive
months); nonpregnancy will be confirmed for all females by a pregnancy test conducted
at screening, (each) admission, and at follow-up.

- Female participants of child-bearing potential must agree to use adequate
contraception from screening until 90 days after the follow-up visit. A

- In good physical health on the basis of no clinically significant findings from
medical history, physical examination (PE), laboratory tests, 12 lead ECG, and vital
signs, as judged by the Investigator.

- Willingness and able to comply with the study protocol, in the investigator's
judgement.

Exclusion Criteria:

- Known history of severe allergic, anaphylactic, or other hypersensitivity reactions to
chimeric, human, or humanized antibodies or fusion proteins.

- Positive drug or alcohol at screening and prior to first dose

- History of alcohol abuse or substance abuse
We found this trial at
5
sites
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Orlando, Florida 32804
Phone: 407-841-0502
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
1635 Divisadero Street
San Francisco, California 94143
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
2075 Bayview Avenue
Toronto, M4N 3M5
?
mi
from
Toronto,
Click here to add this to my saved trials